Reviva Pharmaceuticals Holdings, Inc. (RVPH )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol RVPH
- Company Reviva Pharmaceuticals Holdings, Inc.
- Price $3.57
- Changes Percentage 1589.69
- Change 3.36
- Day Low $0.17
- Day High $3.57
- Year High $24.5
- Year Low $0.17
- Market Cap $243,547,276
- Price Avg 50 EMA (D) $5.7
- Price Avg 200 EMA (D) $9.28
- Exchange NASDAQ
- Volume 9,465,859
- Average Volume 246,847
- Open $0.21
- Previous Close $0.21
- EPS -7.44
- PE -0.48
- Earnings Announcement 2026-03-30 21:00:00
- Shares Outstanding $68,182,328
Company brief: REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH )
- Healthcare
- Biotechnology
- Dr. Laxminarayan Bhat Ph.D.
- https://revivapharma.com
- US
- N/A
- 10-18-2018
- US76152G1004
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.